Page last updated: 2024-11-01

niflumic acid and Adenocarcinoma

niflumic acid has been researched along with Adenocarcinoma in 1 studies

Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research Excerpts

ExcerptRelevanceReference
" In our study, the effects of TNF-alpha, inhibitors of arachidonic acid (AA) metabolism (baicalein, BA; indomethacin, INDO; niflumic acid, NA; nordihydroguaiaretic acid, NDGA), and/or their combinations on undifferentiated or sodium butyrate (NaBt)-differentiated human colon adenocarcinoma HT-29 cells were compared."3.72The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status. ( Hofmanová, J; Kovaríková, M; Kozubík, A; Soucek, K, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kovaríková, M1
Hofmanová, J1
Soucek, K1
Kozubík, A1

Other Studies

1 other study available for niflumic acid and Adenocarcinoma

ArticleYear
The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status.
    Differentiation; research in biological diversity, 2004, Volume: 72, Issue:1

    Topics: Adenocarcinoma; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Butyrates; Caspase 3; Caspases; Cell

2004